Back
Legend Biotech Vs. Biomarin Pharmaceutical Industry Stock Comparison
Sell
16
LEGN
Legend Biotech
Last Price:
44.29
Seasonality Move:
-6.12%
Sell
45
BMRN
Biomarin Pharmaceutical
Last Price:
66.67
Seasonality Move:
14.81%
Sell
16
Legend Biotech (LEGN)
is a Sell
Is Legend Biotech a Buy, Sell or Hold?
- The current Legend Biotech [LEGN] share price is $45.46. The Score for LEGN is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.
- LEGN is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
45
Biomarin Pharmaceutical (BMRN)
is a Sell
Is Biomarin Pharmaceutical a Buy, Sell or Hold?
- The current Biomarin Pharmaceutical [BMRN] share price is $69.92. The Score for BMRN is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
- BMRN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
LEGN Stock Price Chart
What is Legend Biotech's stock price today?
-
The Legend Biotech share price today is $45.46
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LEGN is experiencing slight buying pressure.
BMRN Stock Price Chart
What is Biomarin Pharmaceutical's stock price today?
-
The Biomarin Pharmaceutical share price today is $69.92
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMRN is experiencing slight buying pressure.
LEGN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.46 | Sell |
Relative Strength Index (14 RSI): | 44.93 | Sell |
Chaikin Money Flow: | 226386 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (44.3 - 49.06) | Sell |
Bollinger Bands (100): | (44.97 - 55.87) | Sell |
BMRN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.45 | Sell |
Relative Strength Index (14 RSI): | 39.76 | Sell |
Chaikin Money Flow: | 90332 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (69.27 - 70.47) | Buy |
Bollinger Bands (100): | (73.08 - 88.64) | Sell |
LEGN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 44.36 | Buy |
20-day SMA: | 46.66 | Sell |
50-day SMA: | 50.05 | Sell |
200-day SMA: | 52.31 | Sell |
8-day EMA: | 45.09 | Buy |
20-day EMA: | 46.3 | Sell |
50-day EMA: | 48.62 | Sell |
200-day EMA: | 52.33 | Sell |
BMRN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 70.13 | Sell |
20-day SMA: | 69.85 | Buy |
50-day SMA: | 77.12 | Sell |
200-day SMA: | 83.38 | Sell |
8-day EMA: | 70.07 | Sell |
20-day EMA: | 70.78 | Sell |
50-day EMA: | 74.81 | Sell |
200-day EMA: | 82.2 | Sell |
Legend Biotech Earnings Growth & LEGN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.42 per share, and an increase next year of $0.73 per share.
Biomarin Pharmaceutical Earnings Growth & BMRN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.26 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.18 per share, and an increase next year of $0.95 per share.
Legend Biotech Technical Analysis
Oct 15 | Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
15 | 16 | 18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Biomarin Pharmaceutical Technical Analysis
Oct 15 | Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
15 | 16 | 18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |